Given Twist Bioscience's history of beating EPS estimates but experiencing mixed stock price reactions, the short-term impact is uncertain. However, the overall positive trend in the stock price over the past year suggests a generally bullish outlook from investors. The expected EPS of $-0.78, if met or exceeded, could maintain or slightly improve investor sentiment, but the guidance provided will likely play a crucial role in the immediate stock price movement.